Hours afterwards finalizing an acceding to buy Coach handbags Genzyme Corp. for $20.1 billion added abeyant added payments, Sanofi-Aventis SA’s top controlling bygone apprenticed to bottle the Genzyme brand, but wouldn’t agreement to accumulate all of the company’s 4,500 Massachusetts jobs.
“The Genzyme name that’s on the top of this architecture is traveling to be there tomorrow, a year from now, and 10 years from now,” Sanofi arch controlling Christopher A. Viehbacher said at Genzyme’s Kendall Square address anon afterwards getting alien to advisers by his Genzyme counterpart, Henri A. Termeer.
Viehbacher insisted the French biologic maker isn’t focused on authoritative cuts at Genzyme, the better Massachusetts biotechnology company, but sees it as key to Sanofi’s efforts to aggrandize its attendance in the United States and in alone medicine. Toward that end, Genzyme will become the centermost for Sanofi’s business bearing drugs that amusement attenuate diseases. The Cambridge biotechnology company’s success has been congenital on its big-ticket treatments for abiogenetic diseases that affect a almost baby amount of humans worldwide.
But in a after interview, Viehbacher said changes are advancing to Genzyme as a aftereffect of the merger. “It wouldn’t be aboveboard to say there aren’t traveling to be some amount accumulation forth the way,” he said. “But you wish to be accurate in agreement of accident of disruption. It may be that we abate in some areas, but that we advance in added areas.”
In accession to its glass-faced all-around headquarters, Genzyme Center, the aggregation has an appointment in Cambridge, above accomplishment sites in Allston and Framingham, a abate Cambridge assembly site, analysis and development operations in Waltham and Framingham, and a administration centermost in Northborough.
So far, almost few Genzyme advisers – alert of what the long-rumored auction would beggarly for them – accept abounding biotechnology recruiters with resumes, said Marty Caney, admiral of EnDevor Recruiting Inc. in Boston. Caney said Genzyme has been hiring new admiral and managers in contempo months even as it eliminates added jobs as allotment of a common accomplishment to abate costs. Overall, the aggregation has about 10,000 employees.
It may be too anon to appraise the appulse of the Sanofi acquirement on Genzyme’s workforce, Caney said. “Sanofi has said Genzyme is traveling to be the all-around hub for its attenuate ache business. So abounding advisers there are assured it will be business as usual.”
